🌐 EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

🧪

Trial Match

Clinical trials test new treatments — sometimes the newest options available for a disease. Find trials that are recruiting now, near you. Open one to see its eligibility rules as simple questions to go through with your doctor.

Know your stage or your test results (such as EGFR, HER2 or BRCA)? Match trials to your own profile - nothing you type is saved.

🎯 Match trials to me

30 recruiting trials

for Liposarcoma

Trabectedin Plus Radiotherapy in Soft Tissue Sarcoma Patients NCT02275286Phase 1, Phase 217 sites📍 Bordeaux📍 Lyon📍 Rozzano Grupo Espanol de Investigacion en Sarcomas · Tests: Trabectedin, Radiotherapy START: Safety and Anti-Tumor Activity of PeptiCRAd-1 in Treatment of Cancer NCT05492682Phase 17 sites📍 Frankfurt📍 Heidelberg📍 Tübingen Valo Therapeutics Oy · Tests: PeptiCRAd-1, Cyclophosphamide, Pembrolizumab A Study of Pembrolizumab in People With Ultra-Rare Sarcomas NCT07089992Phase 27 sites📍 Basking Ridge📍 Middletown📍 Montvale Memorial Sloan Kettering Cancer Center · Tests: Pembrolizumab Prospective Study Evaluating the Treatment Outcomes for Localised Recurrent, Resectable Retroperitoneal Liposarcoma NCT07377747n/a13 sites📍 Atlanta📍 Boston📍 Columbus Australia and New Zealand Sarcoma Association A Study to Efficacy and Safety of SPH4336 Monotherapy or in Combination With Cadonilimab in Patients With Advanced Solid Tumors. NCT05944224Phase 1, Phase 216 sites📍 Fuzhou📍 Guangzhou📍 Zhengzhou Shanghai Pharmaceuticals Holding Co., Ltd · Tests: SPH4336, Cadonilimab Immunotherapy for Solid Tumor Malignancies in Pediatrics Using Interleukin-15 and -21 Armored Glypican-3-specific Chimeric Antigen Receptor T Cells NCT07148050Phase 11 site📍 Seattle Seattle Children's Hospital · Tests: SC-CAR.GPC3xIL15.21 CAR T cells Immunotherapy For Adults With GPC3-Positive Solid Tumors Using IL-15 and IL-21 Armored GPC3-CAR T Cells NCT06198296Phase 11 site📍 Houston Baylor College of Medicine · Tests: 21.15.GPC3-CAR T cells Genomic Risk in Retroperitoneal Sarcoma NCT06436846n/a1 site📍 Philadelphia Fox Chase Cancer Center · Tests: Biospecimen sample collection during standard-of-care surgery N-803 in Patients With Progressive Synovial Sarcoma and Myxoid/Round Cell Liposarcoma Previously Treated With Adoptive Cellular Therapy NCT07261657EARLY Phase 11 site📍 Chicago Seth Pollack · Tests: Biospecimen Collection, Computed Tomography, Leukapheresis, Magnetic Resonance Imaging, Nogapendekin Alfa Inbakicept A Phase 3 Study of Ersodetug in Patients With Tumor Hyperinsulinism NCT06881992Phase 313 sites📍 Chicago📍 Bethesda📍 Boston Rezolute · Tests: Ersodetug Phase I/Ib Study of NK Expressing an Affinity-enhanced T-cell Receptor (TCR) Against the NY-ESO-1 NCT06083883Phase 11 site📍 Houston M.D. Anderson Cancer Center · Tests: Fludarabine phosphate, NY-ESO-1 TCR/IL-15 NK, Cyclophosphamide MASCT-I Combined With Doxorubicin and Ifosfamide for First-line Treatment of Advanced Soft Tissue Sarcoma NCT06277154Phase 21 site📍 Guangzhou HRYZ Biotech Co. · Tests: MASCT-I, Doxorubicin, Ifosfamide A Phase 1 Study of Neoadjuvant Abemaciclib in Combination With Radiation Therapy for Liposarcomas NCT06025747Phase 11 site📍 Seattle University of Washington · Tests: Abemaciclib, Computed Tomography, Magnetic Resonance Imaging, Radiation Therapy, Therapeutic Surgical Procedure APG-115 in Combination With PD-1 Inhibitor in Patients With Advanced Liposarcoma or Advanced Solid Tumors NCT04785196Phase 1, Phase 23 sites📍 Guangzhou📍 Hangzhou📍 Shanghai Ascentage Pharma Group Inc. · Tests: APG-115, Toripalimab Hypofractionated, 3-week, Preoperative Proton or X-ray Radiotherapy for Patients With Localized Soft Tissue Sarcoma NCT07169344Phase 24 sites📍 Bergen📍 Oslo📍 Tromsø Oslo University Hospital · Tests: preoperative, Quality of life, Functional outcome Measuring if Immunotherapy Plus Chemotherapy is Better Than Chemotherapy Alone for Patients With Aggressive Poorly Differentiated Sarcomas NCT06422806Phase 3269 sites📍 Phoenix📍 Tucson📍 Tucson National Cancer Institute (NCI) · Tests: Biospecimen Collection, Diagnostic Imaging Testing, Doxorubicin, Echocardiography Test, Multigated Acquisition Scan STC-15 as a Part of Combination Therapy With Toripalimab in Selected Advanced Cancers and as Monotherapy in Participants With Selected Sarcomas NCT06975293Phase 1, Phase 214 sites📍 San Francisco📍 Miami📍 Boston STORM Therapeutics LTD · Tests: STC-15 in combination with toripalimab, STC-15 monotherapy A Phase 2, Open Label Study of PEmigatinib and REtifanlimab in Advanced Dedifferentiated LIposarcoma (PERELI) NCT06389799Phase 24 sites📍 Oslo📍 Gothenburg📍 Lund Lund University Hospital · Tests: Pemigatinib, Retifanlimab IO Combined With AI as First-line Treatment for Patients With Soft Tissue Sarcoma(TAIS) NCT06849986Phase 21 site📍 Shanghai Fudan University · Tests: Tislelizumab+liposomal doxorubicin+ifosfamide Testing the Addition of an Anti-cancer Drug, Abemaciclib, to the Usual Chemotherapy Treatment (Gemcitabine) for Soft Tissue Sarcoma NCT06498648Phase 1, Phase 21 site📍 Houston National Cancer Institute (NCI) · Tests: Abemaciclib, Biopsy Procedure, Biospecimen Collection, Computed Tomography, Docetaxel Testing Low-Dose Common Chemotherapy (Liposomal Doxorubicin) in Combination With an Anti-Cancer Drug, Peposertib, in Advanced Sarcoma NCT05711615Phase 116 sites📍 Los Angeles📍 Los Angeles📍 Aurora National Cancer Institute (NCI) · Tests: Biopsy Procedure, Biospecimen Collection, Computed Tomography, Echocardiography Test, Magnetic Resonance Imaging Study to Test the Safety and Tolerability of PF-07220060 in Participants With Advance Solid Tumors NCT04557449Phase 1, Phase 239 sites📍 Los Angeles📍 New Haven📍 New Haven Pfizer · Tests: PF-07220060, Letrozole, Fulvestrant, Midazolam, Enzalutamide Interleukin-15 and -21 Armored Glypican-3-specific Chimeric Antigen Receptor Expressed in T Cells for Pediatric Solid Tumors NCT04715191Phase 11 site📍 Houston Baylor College of Medicine · Tests: CARE T cells A Study of Mirdametinib in Combination With Palbociclib in People With Liposarcoma NCT06843967Phase 1, Phase 27 sites📍 Basking Ridge📍 Middletown📍 Montvale Memorial Sloan Kettering Cancer Center · Tests: Mirdametinib, Palbociclib A Study of LN-144 or LN-145 in People With Advanced Uveal Melanoma, Undifferentiated Pleomorphic Sarcoma, Dedifferentiated Liposarcoma, or Angiosarcoma NCT05607095Phase 12 sites📍 Harrison📍 New York Memorial Sloan Kettering Cancer Center · Tests: Lifileucel (LN-144/LN-145) A Phase 1, First-in-human Study of OKN4395 and Pembrolizumab in Patients With Solid Tumors NCT06789172Phase 110 sites📍 Beverly Hills📍 Santa Monica📍 Houston Epkin · Tests: OKN4395, Pembrolizumab, Fasting, Fed, H2 Receptor Antagonist NRSTS2021, A Risk Adapted Study Evaluating Maintenance Pazopanib, Limited Margin, Dose-Escalated Radiation Therapy and Selinexor in Non-Rhabdomyosarcoma Soft Tissue Sarcoma (NRSTS) NCT06239272Phase 1, Phase 27 sites📍 Atlanta📍 Chicago📍 Baton Rouge St. Jude Children's Research Hospital · Tests: Surgical resection, Proton beam radiation therapy, Pazopanib, Ifosfamide, Doxorubicin Surgery With or Without Neoadjuvant Chemotherapy in High Risk RetroPeritoneal Sarcoma NCT04031677Phase 3176 sites📍 Birmingham📍 Phoenix📍 Duarte European Organisation for Research and Treatment of Cancer … · Tests: Surgery, Preoperative chemotherapy Silmitasertib (CX-4945) in Combination With Chemotherapy for Relapsed Refractory Solid Tumors NCT06541262Phase 1, Phase 224 sites📍 Birmingham📍 Phoenix📍 Oakland Milton S. Hershey Medical Center · Tests: Silmitasertib, Irinotecan, Temozolomide, Vincristine First-in-Human Trial of DS-2243a in Participants With Advanced Solid Tumors NCT06644755Phase 17 sites📍 Boston📍 New York📍 Nashville Daiichi Sankyo · Tests: DS-2243a
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy